NIFTY 50▲22,147.00
151.15 (0.69%)
SENSEX▲73,088.33
599.34 (0.83%)
NIFTY BANK▲47,574.15
504.70 (1.07%)
TATA MOTORS▼963.20
-8.15 (-0.84%)
INDIAN RAILWAY FINANCE CORP▼141.00
-0.95 (-0.67%)
SUZLON ENERGY▼39.35
-1.80 (-4.37%)
TATA POWER▼428.10
-1.65 (-0.38%)
TATA STEEL▲162.10
2.05 (1.28%)
YES BANK▲23.95
0.05 (0.21%)
INDIAN RENEWABLE ENERGY▼160.70
-2.45 (-1.50%)
RELIANCE INDUSTRIES▲2,940.25
11.60 (0.40%)
RELIANCE POWER▼28.05
-0.65 (-2.26%)
HDFC BANK▲1,531.30
36.60 (2.45%)
RAIL VIKAS NIGAM▼258.45
-1.45 (-0.56%)
VODAFONE IDEA▼12.90
-0.30 (-2.27%)
JIO FIN SERVICES LTD▼370.10
-8.30 (-2.19%)
ADANI POWER▼594.55
-3.55 (-0.59%)
ZOMATO▲189.20
4.00 (2.16%)
NHPC▼87.15
-2.35 (-2.63%)
INDIAN RAILWAY TOURISM CORP▼992.00
-0.95 (-0.10%)
STATE BANK OF INDIA▲750.45
5.65 (0.76%)
INDIAN OIL CORP▼166.65
-2.35 (-1.39%)
MRF▼1,29,157.65
-73.85 (-0.06%)
ITC▲424.75
5.90 (1.41%)
ADANI GREEN ENERGY▼1,770.05
-5.40 (-0.30%)
ADANI ENTERPRISES▲3,026.95
7.65 (0.25%)
JAIPRAKASH POWER VENTURES▼17.05
-0.15 (-0.87%)
ADANI PORT & SEZ▲1,310.00
14.45 (1.12%)
Nectar Lifesciences Share Price
NECLIFE
₹33.80+₹0.65 (1.96%) Past YearLast updated on 19 Apr, 2024 | 03:29 PM IST
₹32.25₹34.35
LH
What’s in news?
Company overview
About
Market cap
| Open₹32.45 | Close₹33.15 |
Circuit range₹39.75 - ₹26.55 | Day range₹32.25 - ₹34.35 | Year range₹16.50 - ₹45.70 |
Volume1,72,310 | Avg. traded₹32.92 | Revenue (12m)₹1,632 Cr |
Nectar LifesciencesNectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.
Read more
Nectar Lifesciences Key indicators
52 week high₹45.70 | 52 week low₹16.50 | P/E ratio91.27 |
P/B ratio0.7 | ROE-2.09% | ROCE2.06% |
Dividend yield-- | Debt/Equity ratio0.71 | EPS-1 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin5.61% | Net profit margin-1.29% |
ROE-2.09% | ROA-0.99% |
ROCE2.06% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
Nectar Lifesciences Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Apr 19 2024 | ₹32.45 | ₹33.30 | |
Thu, Apr 18 2024 | ₹34.15 | ₹33.15 | -3.02% |
Tue, Apr 16 2024 | ₹32.25 | ₹34.15 | |
Mon, Apr 15 2024 | ₹33.50 | ₹32.60 | -2.76% |
Fri, Apr 12 2024 | ₹34.70 | ₹33.85 | -2.51% |
Wed, Apr 10 2024 | ₹34.80 | ₹34.75 | -0.14% |
Tue, Apr 9 2024 | ₹35.45 | ₹34.85 | -1.72% |
Mon, Apr 8 2024 | ₹36.25 | ₹35.45 | -2.26% |
Events
No data available at the moment